Clinical Trials: Why It's Important to Participate

Clinical trials are regulated research studies that try to find better ways to prevent, screen for, diagnose or treat a disease. These critical studies answer specific questions about new interventions—which can be new vaccines, drugs and devices—and measure their effectiveness and safety for patients. The Food and Drug Administration (FDA) regulates clinical trials in the U.S.

Dr. Socinski will cover the benefits of clinical trials and how to decide if they're right for you.

To share a question for Dr. Socinski email and we will answer during the presentation, or in follow-up materials.

Date: Wednesday, January 10, 2024
Time: 1:00 PM - 2:00 PM (EST)

Featured Speaker


Mark A. Socinski, MD
Executive Medical Director
AdventHealth Cancer Institute
Orlando, FL

Dr. Socinski Dr. Mark Socinski is the Executive Medical Director of the AdventHealth Cancer Institute in Orlando, FL. Dr. Socinski received his medical degree from the University of Vermont, College of Medicine. His postdoctoral training included an internship and residency in internal medicine at the Beth Israel Hospital, Harvard Medical School and a medical oncology fellowship at the Dana-Farber Cancer Institute, Harvard Medical School. Dr. Socinski was most recently the Director of the Lung Cancer Section at the University of Pittsburgh Medical Center, Clinical Associate Director of the University of Pittsburgh Lung Cancer SPORE, Co-Director of UPMC Lung Cancer Center of Excellence, and Co-Leader of the Lung Cancer Program at the University of Pittsburgh Cancer Institute.

Dr. Socinski holds membership in numerous professional societies such as the American College of Physicians, American Society of Clinical Oncology, Cancer and Leukemia Group B (Alliance), International Association for the Study of Lung Cancer, American College of Chest Physicians. Dr. Socinski is also co-Chair Emeritus of the Thoracic Malignancies Steering Committee for the National Cancer Institute.

Dr. Socinski is well-published in peer-reviewed literature in outstanding journals as the Journal of Clinical Oncology, Journal of Thoracic Oncology, Cancer, and Lancet Oncology. Dr. Socinski’s primary research interests reside in all aspects of clinical trials related to the thoracic oncology population. He also has been instrumental in the development of many cooperative group and investigator-initiated clinical trials.



Time: 1:00 PM - 2:00 PM

We're sorry, the deadline for registering for this event has passed.